Cargando…

The Interplay of Adipokines and Pancreatic Beta Cells in Metabolic Regulation and Diabetes

The interplay between adipokines and pancreatic beta cells, often referred to as the adipo-insular axis, plays a crucial role in regulating metabolic homeostasis. Adipokines are signaling molecules secreted by adipocytes that have profound effects on several physiological processes. Adipokines such...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Joon, Oh, Chang-Myung, Kim, Hyeongseok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526203/
https://www.ncbi.nlm.nih.gov/pubmed/37761031
http://dx.doi.org/10.3390/biomedicines11092589
_version_ 1785110965955592192
author Kim, Joon
Oh, Chang-Myung
Kim, Hyeongseok
author_facet Kim, Joon
Oh, Chang-Myung
Kim, Hyeongseok
author_sort Kim, Joon
collection PubMed
description The interplay between adipokines and pancreatic beta cells, often referred to as the adipo-insular axis, plays a crucial role in regulating metabolic homeostasis. Adipokines are signaling molecules secreted by adipocytes that have profound effects on several physiological processes. Adipokines such as adiponectin, leptin, resistin, and visfatin influence the function of pancreatic beta cells. The reciprocal communication between adipocytes and beta cells is remarkable. Insulin secreted by beta cells affects adipose tissue metabolism, influencing lipid storage and lipolysis. Conversely, adipokines released from adipocytes can influence beta cell function and survival. Chronic obesity and insulin resistance can lead to the release of excess fatty acids and inflammatory molecules from the adipose tissue, contributing to beta cell dysfunction and apoptosis, which are key factors in developing type 2 diabetes. Understanding the complex interplay of the adipo-insular axis provides insights into the mechanisms underlying metabolic regulation and pathogenesis of metabolic disorders. By elucidating the molecular mediators involved in this interaction, new therapeutic targets and strategies may emerge to reduce the risk and progression of diseases, such as type 2 diabetes and its associated complications. This review summarizes the interactions between adipokines and pancreatic beta cells, and their roles in the pathogenesis of diabetes and metabolic diseases.
format Online
Article
Text
id pubmed-10526203
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105262032023-09-28 The Interplay of Adipokines and Pancreatic Beta Cells in Metabolic Regulation and Diabetes Kim, Joon Oh, Chang-Myung Kim, Hyeongseok Biomedicines Review The interplay between adipokines and pancreatic beta cells, often referred to as the adipo-insular axis, plays a crucial role in regulating metabolic homeostasis. Adipokines are signaling molecules secreted by adipocytes that have profound effects on several physiological processes. Adipokines such as adiponectin, leptin, resistin, and visfatin influence the function of pancreatic beta cells. The reciprocal communication between adipocytes and beta cells is remarkable. Insulin secreted by beta cells affects adipose tissue metabolism, influencing lipid storage and lipolysis. Conversely, adipokines released from adipocytes can influence beta cell function and survival. Chronic obesity and insulin resistance can lead to the release of excess fatty acids and inflammatory molecules from the adipose tissue, contributing to beta cell dysfunction and apoptosis, which are key factors in developing type 2 diabetes. Understanding the complex interplay of the adipo-insular axis provides insights into the mechanisms underlying metabolic regulation and pathogenesis of metabolic disorders. By elucidating the molecular mediators involved in this interaction, new therapeutic targets and strategies may emerge to reduce the risk and progression of diseases, such as type 2 diabetes and its associated complications. This review summarizes the interactions between adipokines and pancreatic beta cells, and their roles in the pathogenesis of diabetes and metabolic diseases. MDPI 2023-09-21 /pmc/articles/PMC10526203/ /pubmed/37761031 http://dx.doi.org/10.3390/biomedicines11092589 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Kim, Joon
Oh, Chang-Myung
Kim, Hyeongseok
The Interplay of Adipokines and Pancreatic Beta Cells in Metabolic Regulation and Diabetes
title The Interplay of Adipokines and Pancreatic Beta Cells in Metabolic Regulation and Diabetes
title_full The Interplay of Adipokines and Pancreatic Beta Cells in Metabolic Regulation and Diabetes
title_fullStr The Interplay of Adipokines and Pancreatic Beta Cells in Metabolic Regulation and Diabetes
title_full_unstemmed The Interplay of Adipokines and Pancreatic Beta Cells in Metabolic Regulation and Diabetes
title_short The Interplay of Adipokines and Pancreatic Beta Cells in Metabolic Regulation and Diabetes
title_sort interplay of adipokines and pancreatic beta cells in metabolic regulation and diabetes
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526203/
https://www.ncbi.nlm.nih.gov/pubmed/37761031
http://dx.doi.org/10.3390/biomedicines11092589
work_keys_str_mv AT kimjoon theinterplayofadipokinesandpancreaticbetacellsinmetabolicregulationanddiabetes
AT ohchangmyung theinterplayofadipokinesandpancreaticbetacellsinmetabolicregulationanddiabetes
AT kimhyeongseok theinterplayofadipokinesandpancreaticbetacellsinmetabolicregulationanddiabetes
AT kimjoon interplayofadipokinesandpancreaticbetacellsinmetabolicregulationanddiabetes
AT ohchangmyung interplayofadipokinesandpancreaticbetacellsinmetabolicregulationanddiabetes
AT kimhyeongseok interplayofadipokinesandpancreaticbetacellsinmetabolicregulationanddiabetes